LAG3 抗体 (N-Term)
Our Local Distributor
北京 101111
Quick Overview for LAG3 抗体 (N-Term) (ABIN6992196)
抗原
See all LAG3 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 110-160, N-Term
-
特异性
- At least two antibodies are known to exist, this antibody will only detect the largest isoform.
-
纯化方法
- LAG3 Antibody is affinity chromatography purified via peptide column.
-
免疫原
- LAG3 antibody was raised against a peptide corresponding to 18 amino acids near the amino terminus of human LAG3. The immunogen is located within amino acids 110 - 160 of LAG3.
-
亚型
- IgG
-
-
-
-
应用备注
-
LAG3 antibody can be used for Western blot at 1 - 2 μ,g/mL. Antibody can also be used for Immunohistochemistry at 5 μ,g/mL. For Immunoflorescence start at 20 μ,g/mL.
Antibody validated: Western Blot in mouse samples, Immunohistochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested. -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- LAG3 Antibody is supplied in PBS containing 0.02 % sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C,4 °C
-
储存方法
- LAG3 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
别名
- LAG3
-
背景
- The lymphocyte activation gene-3 (LAG3) is a member of the immunoglobulin superfamily and binds MHC class II with high affinity (1), negatively regulating T-cell function and homeostasis (2). It is expressed in B, T, and NK cells, monocytes, and dendritic cells (3), and acts to regulate T cell expansion (4). LAG3 is also an important immune checkpoint protein, with anti-LAG3 antibodies activating T effector cells and affecting regulatory T cell functions. Furthermore LAG3 appears to act in a synergistic fashion with PD-1/PD-L1, suggesting that a dual antibody approach may prove useful in cancer immunotherapy (5).
-
分子量
-
Predicted: 55 kDa
Observed: 54 kDa -
基因ID
- 3902
-
NCBI登录号
- NP_002277
-
UniProt
- P18627
-
途径
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
抗原
-